Formation of methionine sulfoxide-containing specific forms of oxidized high-density lipoproteins

Biochimica et Biophysica Acta - Proteins and Proteomics

Volumn 1703, Issue 2, 2005, Pages 171-181

  Panzenböck, Ute ^a   Stocker, Roland ^b  

^a MEDICAL UNIVERSITY OF GRAZ   (Austria)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Atherosclerosis; Lipoprotein; Oxidation; Protein oxidation; Surrogate marker

Indexed keywords

APOLIPOPROTEIN A1; APOLIPOPROTEIN A2; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN; METHIONINE; METHIONINE SULFOXIDE; OXIDIZED LOW DENSITY LIPOPROTEIN; OXIDOREDUCTASE; SCLEROPROTEIN;

ATHEROSCLEROSIS; BIOACCUMULATION; BLOOD VESSEL WALL; CORONARY ARTERY DISEASE; DISEASE MARKER; EXTRACELLULAR MATRIX; HUMAN; IN VIVO STUDY; LIPID PEROXIDATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; PROTEIN LOCALIZATION; REVIEW; TISSUE DISTRIBUTION;

LIPOPROTEINS, LDL; METHIONINE; OXIDATION-REDUCTION;

EID: 12844266113     PISSN: 15709639     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbapap.2004.11.003     Document Type: Review

References (96)

1. D. Steinberg, S. Parthasarathy, T.E. Carew, J.C. Khoo, and J.L. Witztum Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity N. Engl. J. Med. 320 1989 915 924
2. R. Stocker, V.W. Bowry, and B. Frei Ubiquinol-10 protects human low density lipoprotein more efficiently against lipid peroxidation than does α-tocopherol Proc. Natl. Acad. Sci. U. S. A. 88 1991 1646 1650
3. H. Esterbauer, G. Jürgens, O. Quehenberger, and E. Koller Autoxidation of human low density lipoprotein: loss of polyunsaturated fatty acids and vitamin E and generation of aldehydes J. Lipid Res. 28 1987 495 509
4. J.M. Upston, A.C. Terentis, and R. Stocker Tocopherol-mediated peroxidation (TMP) of lipoproteins: implications for vitamin E as a potential antiatherogenic supplement FASEB J. 13 1999 977 994
5. U.P. Steinbrecher, M. Lougheed, W.-C. Kwan, and M. Dirks Recognition of oxidized low density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation J. Biol. Chem. 264 1989 15216 15223
6. S. Ylä-Herttuala, W. Palinski, M.E. Rosenfeld, S. Parthasarathy, T.E. Carew, S. Butler, J.L. Witztum, and D. Steinberg Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man J. Clin. Invest. 84 1989 1086 1095
7. P. Holvoet, G. Perez, Z. Zhao, E. Brouwers, H. Bernar, and D. Collen Malondialdehyde-modified low density lipoproteins in patients with atherosclerotic disease J. Clin. Invest. 95 1995 2611 2619
8. S. Ehara, M. Ueda, T. Naruko, K. Haze, A. Itoh, M. Otsuka, R. Komatsu, T. Matsuo, H. Itabe, T. Takano, Y. Tsukamoto, M. Yoshiyama, K. Takeuchi, J. Yoshikawa, and A.E. Becker Elevated levels of oxidized low density lipoprotein show a positive relationship with the severity of acute coronary syndromes Circulation 103 2001 1955 1960
9. D. Steinberg Oxidized low density lipoprotein-an extreme example of lipoprotein heterogeneity Isr. J. Med. Sci. 32 1996 469 472
10. S. Tsimikas, and J.L. Witztum Measuring circulating oxidized low-density lipoprotein to evaluate coronary risk Circulation 103 2001 1930 1932
11. K.J. Williams, and I. Tabas The response-to-retention hypothesis of early atherogenesis Arterioscler. Thromb. Vasc. Biol. 15 1995 551 561
12. K. Skalen, M. Gustafsson, E.K. Rydberg, L.M. Hulten, O. Wiklund, T.L. Innerarity, and J. Borén Subendothelial retention of atherogenic lipoproteins in early atherosclerosis Nature 417 2002 750 754
13. M.J. Stampfer, F.M. Sacks, S. Salvini, W.C. Willett, and C.H. Hennekens A prospective study of cholesterol, apolipoproteins, and the risk of myocardial infarction New Engl. J. Med. 325 1991 373 381
14. J.A. Glomset The plasma lecithin:cholesterol acyltransferase reaction J. Lipid Res. 9 1968 155 167
15. C.J. Fielding, and P.E. Fielding Molecular physiology of reverse cholesterol transport J. Lipid Res. 36 1995 211 228
16. P. Barter, J. Kastelein, A. Nunn, and R. Hobbs High density lipoproteins (HDLs) and atherosclerosis; the unanswered questions Atherosclerosis 168 2003 195 211
17. V.W. Bowry, K.K. Stanley, and R. Stocker High density lipoprotein is the major carrier of lipid hydroperoxides in fasted human plasma Proc. Natl. Acad. Sci. U. S. A. 89 1992 10316 10320
18. W. Sattler, and R. Stocker Greater selective uptake by Hep G2 cells of high-density lipoprotein cholesteryl ester hydroperoxides than of unoxidized cholesteryl esters Biochem. J. 294 1993 771 778
19. J. Christison, K.-A. Rye, and R. Stocker Exchange of oxidised cholesteryllinoleate between LDL and HDL mediated by cholesteryl ester transfer protein J. Lipid Res. 36 1995 2017 2026
20. J.K. Christison, A. Karjalainen, J. Brauman, F. Bygrave, and R. Stocker Rapid reduction and removal of HDL- but not LDL-associated cholesterylester hydroperoxides by in situ perfused rat liver Biochem. J. 314 1996 739 742
21. K. Fluiter, H. Vietsch, E.A. Biessen, G.M. Kostner, T.J.C. van Berkel, and W. Sattler Increased selective uptake in vivo and in vitro of oxidized cholesteryl esters from high-density lipoprotein by rat liver parenchymal cells Biochem. J. 319 1996 471 476
22. X. Niu, V. Zammit, J.M. Upston, R.T. Dean, and R. Stocker Co-existence of oxidized lipids and α-tocopherol in all lipoprotein fractions isolated from advanced human atherosclerotic plaques Arterioscler. Thromb. Vasc. Biol. 19 1999 1708 1718
23. J.M. Upston, X. Niu, A.J. Brown, R. Mashima, H. Wang, R. Senthilmohan, A.J. Kettle, R.T. Dean, and R. Stocker Disease stage-dependent accumulation of lipid and protein oxidation products in human atherosclerosis Am. J. Pathol. 160 2002 701 710
24. C. Suarna, R.T. Dean, J. May, and R. Stocker Human atherosclerotic plaque contains both oxidized lipids and relatively large amounts of α-tocopherol and ascorbate Arterioscler. Thromb. Vasc. Biol. 15 1995 1616 1624
25. A.C. Terentis, S.R. Thomas, J.A. Burr, D.C. Liebler, and R. Stocker Vitamin E oxidation in human atherosclerotic lesions Circ. Res. 90 2002 333 339
26. J.M. Upston, A.C. Terentis, K. Morris, J.F. Keaney Jr., and R. Stocker Oxidized lipid accumulates in the presence of α-tocopherol in atherosclerosis Biochem. J. 363 2002 753 760
27. J. Borén, K. Olin, I. Lee, A. Chait, T.N. Wight, and T.L. Innerarity Identification of the principal proteoglycan-binding site in LDL. A single-point mutation in apo-B100 severely affects proteoglycan interaction without affecting LDL receptor binding J. Clin. Invest. 101 1998 2658 2664
28. C.G. Brouillette, G.M. Anantharamaiah, J.A. Engler, and D.W. Borhani Structural models of human apolipoprotein A-I: a critical analysis and review Biochim. Biophys. Acta 1531 2001 4 46
29. G.M. Anantharamaiah, T.A. Hughes, M. Iqbal, A. Gawish, P.J. Neame, M.F. Medley, and J.P. Segrest Effect of oxidation on the properties of apolipoproteins A-I and A-II J. Lipid Res. 29 1988 309 318
30. G.M. Anantharamaiah, and D.W. Garber Chromatographic methods for quantitation of apolipoprotein A-I Methods Enzymol. 263 1996 267 282
31. A. von Eckardstein, M. Walter, H. Holz, A. Benninghoven, and G. Assmann Site-specific methionine sulfoxide formation is the structural basis of chromatographic heterogeneity of apolipoproteins A-I, C-II, and C-III J. Lipid Res. 32 1991 1465 1476
32. W. Sattler, M. Maiorino, and R. Stocker Reduction of HDL- and LDL-associated cholesterylester- and phospholipid hydroperoxides by phospholipid hydroperoxide glutathione peroxidase and Ebselen (PZ 51) Arch. Biochem. Biophys. 309 1994 214 221
33. W. Sattler, D. Mohr, and R. Stocker Rapid isolation of lipoproteins and assessment of their peroxidation by HPLC postcolumn chemiluminescence Methods Enzymol. 233 1994 469 489
34. B. Garner, P.K. Witting, A.R. Waldeck, J.K. Christison, M. Raftery, and R. Stocker Oxidation of high density lipoproteins: I. Formation of methionine sulfoxide in apolipoproteins AI and AII is an early event that correlates with lipid peroxidation and can be enhanced by α-tocopherol J. Biol. Chem. 273 1998 6080 6087
35. B. Garner, A.R. Waldeck, P.K. Witting, K.-A. Rye, and R. Stocker Oxidation of high density lipoproteins: II. Evidence for direct reduction of HDL lipid hydroperoxides by methionine residues of apolipoproteins AI and AII J. Biol. Chem. 273 1998 6088 6095
36. U. Panzenböck, L. Kritharides, M. Raftery, K.A. Rye, and R. Stocker Oxidation of methionine residues to methionine sulfoxides does not decrease potential anti-atherogenic properties of apolipoprotein A-I J. Biol. Chem. 275 2000 19536 19544
37. G. Pankhurst, X.L. Wang, D.E. Wilcken, G. Baernthaler, U. Panzenböck, M. Raftery, and R. Stocker Characterization of specifically oxidized apolipoproteins in mildly oxidized high density lipoprotein J. Lipid Res. 44 2003 349 355
38. J.W. Heinecke Oxidants and antioxidants in the pathogenesis of atherosclerosis: implications for the oxidized low density lipoprotein hypothesis Atherosclerosis 141 1998 1 15
39. U. Panzenboeck, S. Raitmayer, H. Reicher, H. Lindner, O. Glatter, E. Malle, and W. Sattler Effects of reagent and enzymatically generated hypochlorite on physicochemical and metabolic properties of high density lipoproteins J. Biol. Chem. 272 1997 29711 29720
40. C. Bergt, K. Oettl, W. Keller, F. Andreae, H.J. Leis, E. Malle, and W. Sattler Reagent or myeloperoxidase-generated hypochlorite affects discrete regions in lipid-free and lipid-associated human apolipoprotein A-I Biochem. J. 346 2000 345 354
41. C. Bergt, S. Pennathur, X. Fu, J. Byun, K. O'Brien, T.O. McDonald, P. Singh, G.M. Anantharamaiah, A. Chait, J. Brunzell, R.L. Geary, J.F. Oram, and J.W. Heinecke The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport Proc. Natl. Acad. Sci. U. S. A. 101 2004 13032 13037
42. L. Zheng, B. Nukuna, M.L. Brennan, M. Sun, M. Goormastic, M. Settle, D. Schmitt, X. Fu, L. Thomson, P.L. Fox, H. Ischiropoulos, J.D. Smith, M. Kinter, and S.L. Hazen Apolipoprotein A-I is a selective target for myeloperoxidase- catalyzed oxidation and functional impairment in subjects with cardiovascular disease J. Clin. Invest. 114 2004 529 541
43. S. Pennathur, C. Bergt, B. Shao, J. Byun, S.Y. Kassim, P. Singh, P.S. Green, T.O. McDonald, J. Brunzell, A. Chait, J.F. Oram, K. O'Brien, R.L. Geary, and J.W. Heinecke Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by Reactive Nitrogen Species J. Biol. Chem. 279 2004 42977 42983
44. E.A. Podrez, H.M. Abu-Soud, and S.L. Hazen Myeloperoxidase-generated oxidants and atherosclerosis Free Radic. Biol. Med. 28 2000 1717 1725
45. R. Zhang, M.L. Brennan, Z. Shen, J.C. MacPherson, D. Schmitt, C.E. Molenda, and S.L. Hazen Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation J. Biol. Chem. 277 2002 46116 46122
46. R. Stocker, and J.F. Keaney Jr. The role of oxidative modifications in atherosclerosis Physiol. Rev. 84 2004 1381 1478
47. V.W. Bowry, and R. Stocker Tocopherol-mediated peroxidation. The pro-oxidant effect of vitamin E on the radical-initiated oxidation of human low-density lipoprotein J. Am. Chem. Soc. 115 1993 6029 6044
48. J. Neuzil, S.R. Thomas, and R. Stocker Requirement for, promotion, or inhibition by α-tocopherol of radical-induced initiation of plasma lipoprotein lipid peroxidation Free Radic. Biol. Med. 22 1997 57 71
49. R. Stocker The ambivalence of vitamin E in atherogenesis T.I.B.S. 24 1999 219 223
50. H.B. Brewer Jr., S.E. Lux, R. Ronan, and K.M. John Amino acid sequence of human apoLp-Gln-II (apoA-II), an apolipoprotein isolated from the high-density lipoprotein complex J. Biol. Chem. 69 1972
51. W.A. Pryor, X. Jin, and G.L. Squadrito One- and two-electron oxidations of methionine by peroxynitrite Proc. Natl. Acad. Sci. U. S. A. 91 1994 11173 11177
52. J.L. Jensen, B.L. Miller, X. Zhang, G.L. Hug, and C. Schöneich Oxidation of threonylmethionine by peroxynitrite. Quantification of the one-electron transfer pathway by comparison to one-electron photooxidation J. Am. Chem. Soc. 119 1997 4749 4757
53. W. Sattler, J.K. Christison, and R. Stocker Cholesterylester hydroperoxide reducing activity associated with isolated high- and low-density lipoproteins Free Radic. Biol. Med. 18 1995 421 429
54. H. Chung, A. Randolph, I. Reardon, and R.L. Heinrikson The covalent structure of apolipoprotein A-I from canine high density lipoproteins J. Biol. Chem. 257 1982 2961 2967
55. A.B. Smith, and S.L. Hajduk Identification of haptoglobin as a natural inhibitor of trypanocidal activity in human serum Proc. Natl. Acad. Sci. U. S. A. 92 1995 10262 10266
56. S.L. Hajduk, D.R. Moore, J. Vasudevacharya, H. Siqueira, A.F. Torri, E.M. Tytler, and J.D. Esko Lysis of Trypanosoma brucei by a toxic subspecies of human high density lipoprotein J. Biol. Chem. 264 1989 5210 5217
57. J. March Advanced Organic Chemistry. Reactions, Mechanisms, and Structure second edition 1977 McGraw-Hill New York
58. Y. Shechter, Y. Burstein, and A. Patchornik Selective oxidation of methionine residues in proteins Biochemistry 14 1975 4497 4503
59. H. Fliss, H. Weissbach, and N. Brot Oxidation of methionine residues in proteins of activated human neutrophils Proc. Natl. Acad. Sci. U. S. A. 80 1983 7160 7164
60. R.G. Keck The use of t-butyl hydroperoxide as a probe for methionine oxidation in proteins Anal. Biochem. 236 1996 56 62
61. S. Rapoport, B. Härtel, and G. Hausdorf Methionine sulfoxide formation: the cause of self-inactivation of reticulocyte lipoxygenase Eur. J. Biochem. 139 1984 573 576
62. Q.F. Gan, G.L. Witkop, D.L. Sloane, K.M. Straub, and E. Sigal Identification of a specific methionine in mammalian 15-lipoxygenase which is oxygenated by the enzyme product 13-HPODE: dissociation of sulfoxide formation from self-inactivation Biochemistry 34 1995 7069 7079
63. N. Brot, and H. Weissbach Biochemistry and physiological role of methionine sulfoxide residues in proteins Arch. Biochem. Biophys. 223 1983 271 281
64. C.B. Glaser, L. Karic, S. Parmelee, B.R. Premachandra, D. Hinkston, and W.R. Abrams Studies on the turnover of methionine oxidized alpha-1-protease inhibitor in rats Am. Rev. Respir. Dis. 136 1987 857 861
65. J. Moskovitz, N.A. Jenkins, D.J. Gilbert, N.G. Copeland, F. Jursky, H. Weissbach, and N. Brot Chromosomal localization of the mammalian peptide-methionine sulfoxide reductase gene and its differential expression in various tissues Proc. Natl. Acad. Sci. U. S. A. 93 1996 3205 3208
66. J. Moskovitz, H. Weissbach, and N. Brot Cloning and expression of a mammalian gene involved in the reduction of methionine sulfoxide residues in proteins Proc. Natl. Acad. Sci. U. S. A. 93 1996 2095 2099
67. A.B. Sigalov, and L.J. Stern Enzymatic repair of oxidative damage to human apolipoprotein A-I FEBS Lett. 433 1998 196 200
68. A.B. Sigalov, and L.J. Stern Dihydrolipoic acid as an effective cofactor for peptide methionine sulfoxide reductase in enzymatic repair of oxidative damage to both lipid-free and lipid-bound apolipoprotein A-I Antioxid. Redox Signal. 4 2002 553 557
69. V.S. Sharov, D.A. Ferrington, T.C. Squier, and C. Schoneich Diastereoselective reduction of protein-bound methionine sulfoxide by methionine sulfoxide reductase FEBS Lett. 455 1999 247 250
70. M. Bodzioch, E. Orso, J. Klucken, T. Langmann, A. Bottcher, W. Diederich, W. Drobnik, S. Barlage, C. Buchler, M. Porsch-Ozcurumez, W.E. Kaminski, H.W. Hahmann, K. Oette, G. Rothe, C. Aslanidis, K.J. Lackner, and G. Schmitz The gene encoding ATP-binding cassette transporter 1 is mutated in Tangier disease Nat. Genet. 22 1999 347 551
71. R.M. Lawn, D.P. Wade, M.R. Garvin, X. Wang, K. Schwartz, J.G. Porter, J.J. Seilhamer, A.M. Vaughan, and J.F. Oram The Tangier disease gene product ABC1 controls the cellular apolipoprotein-mediated lipid removal pathway J. Clin. Invest. 104 1999 R25 R31
72. M. Marcil, A. Brooks-Wilson, S.M. Clee, K. Roomp, L.H. Zhang, L. Yu, J.A. Collins, M. van Dam, H.O. Molhuizen, O. Loubster, B.F. Ouellette, C.W. Sensen, K. Fichter, S. Mott, M. Denis, B. Boucher, S. Pimstone, J. Genest Jr., J.J. Kastelein, and M.R. Hayden Mutations in the ABC1 gene in familial HDL deficiency with defective cholesterol efflux Lancet 354 1999 1341 1346
73. Y. Ji, B. Jian, N. Wang, Y. Sun, M.L. Moya, M.C. Phillips, G.H. Rothblat, J.B. Swaney, and A.R. Tall Scavenger receptor BI promotes high density lipoprotein-mediated cellular cholesterol efflux J. Biol. Chem. 272 1997 20982 20985
74. G. Kellner-Weibel, M. de La Llera-Moya, M.A. Connelly, G. Stoudt, A.E. Christian, M.P. Haynes, D.L. Williams, and G.H. Rothblat Expression of scavenger receptor BI in COS-7 cells alters cholesterol content and distribution Biochemistry 39 2000 221 229
75. Y. Nagano, H. Arai, and T. Kita High density lipoprotein loses its effect to stimulate efflux of cholesterol from foam cells after oxidative modification Proc. Natl. Acad. Sci. U. S. A. 88 1991 6457 6461
76. G. Marsche, R. Zimmermann, S. Horiuchi, N.N. Tandon, W. Sattler, and E. Malle Class B scavenger receptors CD36 and SR-BI are receptors for hypochlorite-modified low density lipoprotein J. Biol. Chem. 278 2003 47562 47570
77. G.A. Francis, A.J. Mendez, E.L. Bierman, and J.W. Heinecke Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells Proc. Natl. Acad. Sci. U. S. A. 90 1993 6631 6635
78. D.L. Macdonald, T.L. Terry, L.B. Agellon, P.N. Nation, and G.A. Francis Administration of tyrosyl radical-oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E-deficient mice Arterioscler. Thromb. Vasc. Biol. 23 2003 1583 1588
79. W.-Q. Wang, D.L. Merriam, A.S. Moses, and G.A. Francis Enhanced cholesterol efflux by tyrosyl radical-oxidized high density lipoprotein is mediated by apolipoprotein AI-AII heterodimers J. Biol. Chem. 273 1998 17391 17398
80. C. Bergt, J.F. Oram, and J.W. Heinecke Oxidized HDL: the paradoxidation of lipoproteins Arterioscler. Thromb. Vasc. Biol. 23 2003 1488 1490
81. J.P. Segrest, M.K. Jones, H. De Loof, C.G. Brouillette, Y.V. Venkatachalapathi, and G.M. Anantharamaiah The amphipathic helix in the exchangable apolipoproteins: a review of secondary structure and function J. Lipid Res. 33 1992 141 166
82. M.G. Sorci-Thomas, L. Curtiss, J.S. Parks, M.J. Thomas, M.W. Kearns, and M. Landrum The hydrophobic face orientation of apolipoprotein A-I amphipathic helix domain 143-164 regulates lecithin:cholesterol acyltransferase activation J. Biol. Chem. 273 1998 11776 11782
83. A.B. Sigalov, and L.J. Stern Oxidation of methionine residues affects the structure and stability of apolipoprotein A-I in reconstituted high density lipoprotein particles Chem. Phys. Lipids 113 2001 133 146
84. L.M. Roberts, M.J. Ray, T.W. Shih, E. Hayden, M.M. Reader, and C.G. Brouillette Structural analysis of apolipoprotein A-I: limited proteolysis of methionine-reduced and -oxidized lipid-free and lipid-bound human apo A-I Biochemistry 36 1997 7615 7624
85. A.B. Sigalov, I.E. Petrichenko, and G.V. Kolpakova The ratio of non-oxidized/oxidized forms of apolipoprotein A-I can affect cholesterol efflux from human skin fibroblasts mediated by high density lipoprotein Eur. J. Clin. Chem. Clin. Biochem. 35 1997 395 396
86. A. Jonas, A. von Eckardstein, L. Churgay, W.W. Mantulin, and G. Assmann Structural and functional properties of natural and chemical variants of apolipoprotein A-I Biochim. Biophys. Acta 1166 1993 202 210
87. D.W. Borhani, D.P. Rogers, J.A. Engler, and C.G. Brouillette Crystal structure of truncated human apolipoprotein A-I suggests a lipid-bound conformation Proc. Natl. Acad. Sci. U. S. A. 94 1997 12291 12296
88. A.R. Waldeck, and R. Stocker Radical-initiated lipid peroxidation in low density lipoproteins: insights obtained from kinetic modeling Chem. Res. Toxicol. 9 1996 954 964
89. S. Roosbeek, B. Vanloo, N. Duverger, H. Caster, J. Breyne, I. De Beun, H. Patel, J. Vandekerckhove, C. Shoulders, M. Rosseneu, and F. Peelman Three arginine residues in apolipoprotein A-I are critical for activation of lecithin:acyltransferase J. Lipid Res. 42 2001 31 40
90. H.Q. Liang, K.-A. Rye, and P.J. Barter Dissociation of lipid-free apolipoprotein A-I from high density lipoprotein J. Lipid Res. 35 1994 1187 1199
91. S. Yokoyama Apolipoprotein-mediated cellular cholesterol efflux Biochim. Biophys. Acta 1392 1998 1 15
92. J.F. Oram, and S. Yokoyama Apolipoprotein-mediated removal of cellular cholesterol and phospholipids J. Lipid Res. 37 1996 2473 2491
93. P.K. Witting, C. Westerlund, and R. Stocker A rapid and simple screening test for potential inhibitors of tocopherol-mediated peroxidation of LDL lipids J. Lipid Res. 37 1996 853 867
94. J.D. Morrow, and L.J. Roberts The isoprostanes: unique bioactive products of lipid peroxidation Prog. Lipid Res. 36 1997 1 21
95. X.L. Wang, A.S. Sim, R.F. Badenhop, R.M. McCredie, and D.E. Wilcken A smoking-dependent risk of coronary artery disease associated with a polymorphism of the endothelial nitric oxide synthase gene Nat. Med. 2 1996 41 45
96. A. Jonas, A. Steinmetz, and L. Churgay The number of amphipathic alpha-helical segments of apolipoproteins A-I, E, and A-IV determines the size and functional properties of their reconstituted lipoprotein particles J. Biol. Chem. 268 1993 1596 1602